Salt T E, Eaton S A, Turner J P
Department of Visual Science, University College London, U.K.
Neurochem Int. 1996 Sep;29(3):317-22. doi: 10.1016/0197-0186(95)00146-8.
The ventrobasal thalamus (VB) relays and processes somatosensory information ascending to the cerebral cortex. Several types of mGluR are known to be present in VB, and we have previously shown that Group II and Group III mGluR agonists can reduce inhibitory synaptic transmission by acting at presynaptic receptors on GABAergic terminals in this structure. We have tested the action of several antagonists against the disinhibitory action of the Group II agonist CCG-I [(2S,3S,4S)-alpha-(carboxycyclopropyl)-glycine] and the Group III agonist L-AP4 [L-2-amino-4-phosphonobutyrate] in the VB of anaesthetized rats using extracellular single-neurone recording techniques and iontophoretic applications of mGluR antagonists and agonists. The antagonists MAP4 [alpha-methyl-L-AP4] and MPPG [(+/-)-alpha-methyl-4-phosphonophenylglycine] reduced the disinhibitory actions of L-AP4 whilst having little effect on the disinhibitory action of CCG-I. In contrast, MCCG [alpha-methyl-CCG-I] and MCPG [(+)-alpha-methyl-4-carboxyphenylglycine] antagonized CCG-I, whilst having less effect against L-AP4 responses. These results support the hypothesis that GABAergic inhibitory transmission in VB can be modulated by at least two types of mGluR, belonging to Group II and Group III. Furthermore, the novel antagonists appear to be useful tools for the future study of the physiological role of these receptors in thalamic sensory processing.
腹侧基底丘脑(VB)传递并处理向大脑皮层上行的躯体感觉信息。已知VB中存在几种类型的代谢型谷氨酸受体(mGluR),并且我们之前已经表明,II组和III组mGluR激动剂可以通过作用于该结构中GABA能终末的突触前受体来减少抑制性突触传递。我们使用细胞外单神经元记录技术以及mGluR拮抗剂和激动剂的离子电泳应用,测试了几种拮抗剂对II组激动剂CCG-I [(2S,3S,4S)-α-(羧基环丙基)-甘氨酸]和III组激动剂L-AP4 [L-2-氨基-4-膦酰丁酸]在麻醉大鼠VB中的去抑制作用的影响。拮抗剂MAP4 [α-甲基-L-AP4]和MPPG [(±)-α-甲基-4-膦酰苯甘氨酸]减少了L-AP4的去抑制作用,而对CCG-I的去抑制作用影响很小。相反,MCCG [α-甲基-CCG-I]和MCPG [(+)-α-甲基-4-羧基苯甘氨酸]拮抗CCG-I,而对L-AP4反应的影响较小。这些结果支持这样的假说,即VB中的GABA能抑制性传递可由至少两种属于II组和III组的mGluR调节。此外,这些新型拮抗剂似乎是未来研究这些受体在丘脑感觉处理中的生理作用的有用工具。